Novel Drug Delivery Systems Market Outlook 2026–2030 Driven By Growth Factors And Projections
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Novel Drug Delivery Systems Market Expected To Change From 2026 To 2030? _x000D_
The novel drug delivery systems market size has seen significant rapid growth in recent years. It is anticipated to increase from $117.66 billion in 2025 to $129.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. The expansion observed historically can be linked to factors such as the rising incidence of chronic diseases, the inherent limitations of conventional drug delivery techniques, the burgeoning oncology and biologics pipeline, an increase in healthcare expenditure, and advancements made in polymer and nanotechnology._x000D_
_x000D_
The novel drug delivery systems market is projected to experience substantial growth in the coming years, with its size anticipated to reach $187.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This expansion during the forecast period is attributable to the surge in personalized and precision medicine, increasing demand for targeted cancer therapies, augmented investment in pharmaceutical research and development, the broadening scope of biologics and biosimilars, and regulatory support for advanced drug delivery technologies. Prominent trends identified for this period include the wider application of targeted and personalized drug delivery, the rising adoption of lipid and polymeric nanoparticles, the development of long-acting and controlled-release formulations, a heightened emphasis on non-invasive and patient-centric delivery routes, and accelerated research and development in combination and hybrid NDDS platforms._x000D_
_x000D_
#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_
_x000D_
Which Factors Are Influencing The Growth Of The Novel Drug Delivery Systems Market?_x000D_
The novel drug delivery systems market is anticipated to experience growth driven by the increasing incidence of neurological disorders. A neurological disorder like stroke is defined as a medical condition where there is a sudden loss of neurological function due to an interruption of blood supply to the brain, either through a blockage (ischemic stroke) or the rupture of a blood vessel (hemorrhagic stroke), leading to brain tissue damage and potential long-term cognitive, sensory, or motor impairments. The escalating occurrence of neurological disorders is primarily fueled by factors such as an aging population, a higher prevalence of lifestyle-related conditions including hypertension, diabetes, and obesity, and increased exposure to chronic stress and environmental risk factors. Novel drug delivery systems facilitate the management of neurological disorders by enabling the targeted and controlled delivery of therapeutics across the blood-brain barrier. For example, in November 2024, data from the National Health Service (NHS) England, a UK-based healthcare system, indicated that stroke admissions in England rose to 111,137 in 2023/24, with the 50–59 age group showing the most substantial increase at 12,533 cases. Thus, the escalating numbers of neurological disorder cases are propelling the expansion of the novel drug delivery systems market._x000D_
_x000D_
What Are The Main Segments Within The Novel Drug Delivery Systems Market Segment Structure?_x000D_
The novel drug delivery systems market covered in this report is segmented – _x000D_
_x000D_
1) By Formulation Type: Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers_x000D_
2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems_x000D_
3) By Route: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes_x000D_
4) By Therapeutic Area: Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases_x000D_
5) By End-User: Hospital, Specialty Clinics, Research Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Liposomes: PEGylated Liposomes, Cationic Liposomes, Stealth Liposomes, Immunoliposomes_x000D_
2) By Nanoparticles: Polymeric Nanoparticles, Lipid Nanoparticles, Metallic Nanoparticles, Nanocrystals_x000D_
3) By Microspheres: Biodegradable Microspheres, Magnetic Microspheres, Radioactive Microspheres, Mucoadhesive Microspheres_x000D_
4) By Hydrogels: Thermosensitive Hydrogels, Ph-Responsive Hydrogels, Injectable Hydrogels, Smart Hydrogels_x000D_
5) By Dendrimers: PAMAM Dendrimers, PPI Dendrimers, Pegylated Dendrimers, Hybrid Dendrimers_x000D_
_x000D_
Which Trends Are Influencing Demand In The Novel Drug Delivery Systems Market?_x000D_
Major companies operating in the novel drug delivery systems market are focused on developing advanced solutions, such as oral thin films, to improve patient adherence and therapeutic effectiveness. An oral thin film is a medication delivery system made up of a fast-dissolving film strip placed in the oral cavity, designed to release medicine directly into the bloodstream through the mucosal membrane. For instance, in February 2024, CD Formulation, a US-based pharmaceutical formulation company, launched Oral Thin Film Technology. This product allows for rapid drug absorption by bypassing gastrointestinal and liver metabolism, making it particularly suitable for patients who struggle with swallowing. It also supports accurate dosing and a quicker onset of action, thereby enhancing treatment precision and convenience across various therapeutic applications._x000D_
_x000D_
Who Are The Companies Participating In The Novel Drug Delivery Systems Market?_x000D_
Major companies operating in the novel drug delivery systems market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche AG, Merck And Co Inc, AbbVie Inc, Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited, Catalent Inc, Evonik Industries AG _x000D_
_x000D_
#Get The Full Novel Drug Delivery Systems Market Report:#_x000D_
_x000D_
Where Is The Novel Drug Delivery Systems Market Primarily Concentrated By Region?_x000D_
North America was the largest region in the novel drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novel drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request A Customized Novel Drug Delivery Systems Market Report For Competitive Insights:#_x000D_
_x000D_
#Browse Through More Reports Similar to the Global Novel Drug Delivery Systems Market 2026, By The Business Research Company#_x000D_
_x000D_
Electronic Drug Delivery Systems Market Report 2026_x000D_
_x000D_
Pharmaceutical Drug Delivery Market Report 2026_x000D_
_x000D_
Smart Drug Delivery Systems Market Report 2026_x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
